Schedule 13G ownership disclosure
REPROS THERAPEUTICS INC.
Security class unavailable · CUSIP: 76028H209
Event date: 2018-01-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,332,292
- Percent of class
- 8.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001019056-18-000004
- Form type
- SC 13G
- Filer
- REPROS THERAPEUTICS INC.
- CIK
- CIK 897075
- Filed
- Jan 02, 2018
- Reporting period
- Jan 02, 2018
- Description
- Schedule 13G beneficial ownership